Close

Shut down of the duforlavigne.com website

 

The www.dufortlavigne.com website will cease to operate at 13:00 on Thursday 13 February and it will no longer be possible to place orders or view products. You can browse the product catalogue on medline.ca

 

Medline Terrebonne's (formerly Dufort and Lavigne) office and Distribution Center will be consolidating to the Medline Canada ERP platform. All future activities will be transferred to Medline Canada's SAP system effective February 17, 2025.​

 

––––

 

From 1 February 2025, you must have a customer account in the SAP system if you want to place an order.​

 

  • If you are a clinic, a company or if you have placed more than 2 orders during the past year, we will automatically create a customer’s account for you. We’ll give you your account number when you place your next order, by email or by phone.
  • If this is not your situation, and you plan to order more than once from Medline, you can request an account by clicking here

 

For customers who do not have a customer’s account with Medline Canada, it will no longer be possible to place orders on the dufortlavigne.com website, by email or by telephone as of February 1.​

 

For more details

 

Celestone Soluspan 6 mg/mL Injectable Glucocorticoid

Merck Canada

Retourner à la boutique
Pun103035-large

WARNING

Special Order

This product carries an Expiry Date of less than 6 months at all times.

This product is sold strictly to healthcare professionals who hold a practice Licence.
  • Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP
  • Anti-inflammatory, antirheumatic and antiallergic effects in the treatment of corticosteroid-responsive disorders : prompt therapeutic activity is achieved by betamethasone sodium phosphate, which is absorbed quickly after injection and sustained activity is provided by betamethasone acetate, which is only slightly soluble and becomes a repository for slow absorption, thereby controlling symptoms over a prolonged period
  • Indications :
  • - I.M. injection in allergic, dermatologic, rheumatic, and other conditions responsive to systemic corticosteroids, including bursitis
  • - injection directly into the affected tissues in bursitis and associated inflammatory disorders of tendons such as tenosynovitis, and inflammatory disorders of muscle such as fibrosis and myositis
  • - intra-articular and periarticular injection in rheumatoid arthritis and osteoarthritis
  • - intralesional injection in various dermatologic conditions; and local injection in certain inflammatory and cystic disorders of the foot

Merck Canada

Documentation

Select a product

PUN103035 1-mL glass vial
*
PUN274530 5-mL Multidose glass vial
x
 

Related Products